Your browser doesn't support javascript.
loading
Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.
Hamilton, Robert J; Canil, Christina; Shrem, Noa Shani; Kuhathaas, Kopika; Jiang, Maria Di; Chung, Peter; North, Scott; Czaykowski, Piotr; Hotte, Sebastien; Winquist, Eric; Kollmannsberger, Christian; Aprikian, Armen; Soulières, Denis; Tyldesley, Scott; So, Alan I; Power, Nicholas; Rendon, Ricardo A; O'Malley, Martin; Wood, Lori; Jewett, Michael A S.
Affiliation
  • Hamilton RJ; Department of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Canil C; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada.
  • Shrem NS; Department of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada.
  • Kuhathaas K; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Jiang MD; Department of Medicine, Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Chung P; Department of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
  • North S; Department of Oncology, Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Czaykowski P; Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
  • Hotte S; Division of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Winquist E; Division of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
  • Kollmannsberger C; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
  • Aprikian A; Division of Urology, Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
  • Soulières D; Division of Medical Oncology/Hematology, Le Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
  • Tyldesley S; Department of Radiation Oncology, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada.
  • So AI; Department of Urologic Sciences, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada.
  • Power N; Division of Urology, Department of Surgery, Western University, London, ON, Canada.
  • Rendon RA; Division of Urology, Department of Surgery, Capital Health - Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
  • O'Malley M; Department of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
  • Wood L; Division of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Can Urol Assoc J ; 16(6): 155-173, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35623007

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Can Urol Assoc J Year: 2022 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Can Urol Assoc J Year: 2022 Document type: Article Affiliation country: Canada